# High-density Activation Mapping of the Slow Pathwayto Guide Catheter Ablation in Patients With Typical Atrioventricular Nodal Reentrant Tachycardia

Study · id `cardio:ct-nct05531903` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05531903](<https://clinicaltrials.gov/study/NCT05531903>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05531903

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

## Technical summary

Registry record NCT05531903. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-15 (actual); primary completion 2023-07-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT05531903, source copy `cardio:ctgov-nct05531903-2024-04-12`, retrieved 2026-10-26)
- Started: 2022-10-15 (actual) (ClinicalTrials.gov record NCT05531903, source copy `cardio:ctgov-nct05531903-2024-04-12`, retrieved 2026-10-26)
- Primary completion: 2023-07-30 (actual) (ClinicalTrials.gov record NCT05531903, source copy `cardio:ctgov-nct05531903-2024-04-12`, retrieved 2026-10-26)
- Completion: 2023-09-01 (actual) (ClinicalTrials.gov record NCT05531903, source copy `cardio:ctgov-nct05531903-2024-04-12`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT05531903, source copy `cardio:ctgov-nct05531903-2024-04-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05531903-2024-04-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: High-density Activation Mapping of the Slow Pathwayto Guide Catheter Ablation in Patients With Typical Atrioventricular Nodal Reentrant Tachycardia
- Condition: Supraventricular Tachycardia
- Condition: Atrioventricular Nodal Re Entrant Tachycardia
- Intervention (Device): Description of Slow pathway signals to facilitate ablation
- Lead sponsor: Parc de Salut Mar
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Parc de Salut Mar (`cardio:org-parc-de-salut-mar`)

## Provenance

Content hash: 1069ce7a05ad6fff9d26cc865357554a2651c8f677d13a1e54377cb6c57f8ee3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
